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The first goal in the COVID-19 pandemic is to limit the spread of the virus. In order to prevent infection of an entire specialty group, departments should consider adopting a team-based practice model to limit cross-contamination. Each team consists of a ratio of providers based on individual institution's workforce. For example, one team in our department consists of one attending physician, two resident physicians, two nurses or medical assistants, and one supportive staff member. Individuals are only in the clinic if their team is conducting in-person visits that day. They are not allowed to have in-person contact with members outside of their designated team. In the event that a team member is exposed to or tests positive for COVID-19, only individuals within their team are required to self-quarantine for 14 days and/or be subsequently tested. By using this approach, cross-contamination is limited; and thus, the department can continue to operate and deliver in-person care in spite of COVID-19 exposure.
In order to continue effective patient care while limiting exposure, we have implemented a coded triaging system which allows us to prioritize and provide the appropriate care for each patient (Figure 1) . A key step is to implement this model as early as possible in combination with teledermatology as other practices have already suggested. 2, 3 As depicted in the diagram, patients with high acuity such as individuals with concerning lesions and potentially lifethreatening eruptions have priority for in-person visits. Simultaneously, continuity of care for existing patients can be achieved through teledermatology. In this system, patients can continue long-term management while decreasing the risk of exposure.
As in-patient visits are avoidable, Chen et al. detailed additional precautions that can be implemented to reduce COVID-19 spread. 1 Recommendations included allowing only one accompanying person per patient, mask usage and temperature reading for people entering both inpatient and outpatient buildings, and the use of personal protective equipment (PPE) (when working with suspected or confirmed COVID-19 patients) by team members during work. We agree with these recommendations although PPE has been in short supply restricting successful implementation. Alternatively, sterilization of PPE equipment can help mitigate this limitation.
The COVID-19 outbreak has been challenging and the medical community has united together to halt the spread. As the COVID-19 outbreak continues to evolve, we hope to develop and implement procedures that both limit the spread of COVID-19 while ensuring that optimal patient care is achieved in dermatology. Once again, we thank the authors for their contribution to improving patient care and safety during this unprecedented time. New patient visit unless specific to something already listed in "Red"
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